These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3366163

  • 1. Inhibition by picotamide of thromboxane production in vitro and ex vivo.
    Violi F, Ghiselli A, Iuliano L, Praticò D, Alessandri C, Balsano F.
    Eur J Clin Pharmacol; 1988; 33(6):599-602. PubMed ID: 3366163
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets.
    Berrettini M, De Cunto M, Parise P, Grasselli S, Nenci GG.
    Eur J Clin Pharmacol; 1990; 39(5):495-500. PubMed ID: 1963845
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of N,N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets.
    Gresele P, Deckmyn H, Arnout J, Nenci GG, Vermylen J.
    Thromb Haemost; 1989 Jun 30; 61(3):479-84. PubMed ID: 2552606
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of the effects of anti-thromboxane agents in platelet-vessel wall interaction.
    Buccellati C, Ciceri P, Ballerio R, Casagrande C, Folco G, Nicosia S.
    Eur J Pharmacol; 2002 May 17; 443(1-3):133-41. PubMed ID: 12044803
    [Abstract] [Full Text] [Related]

  • 8. Binding kinetics and antiplatelet activities of picotamide, a thromboxane A2 receptor antagonist.
    Modesti PA, Cecioni I, Colella A, Costoli A, Paniccia R, Neri Serneri GG.
    Br J Pharmacol; 1994 May 17; 112(1):81-6. PubMed ID: 8032666
    [Abstract] [Full Text] [Related]

  • 9. The in vivo antiplatelet effects of thromboxane A2 synthase inhibitors are potentiated by simultaneous thromboxane A2/prostaglandin H2 receptor blockade.
    Golino P, Ambrosio G, Gresele P, Pascucci I, Ragni M, Russolillo E, Leproux GB, Chiariello M.
    J Pharmacol Exp Ther; 1993 Aug 17; 266(2):511-7. PubMed ID: 8355187
    [Abstract] [Full Text] [Related]

  • 10. Effect of picotamide on platelet aggregation and on thromboxane A2 production in vivo.
    Minuz P, Lechi C, Arosio E, Guzzo P, Zannoni M, Lauciello C, Lechi A.
    Thromb Haemost; 1991 Mar 04; 65(3):312-6. PubMed ID: 2048055
    [Abstract] [Full Text] [Related]

  • 11. The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users.
    Norris LA, Devitt M, Bonnar J.
    Thromb Res; 1996 Feb 15; 81(4):407-17. PubMed ID: 8907290
    [Abstract] [Full Text] [Related]

  • 12. Effect of picotamide on the calcium mobilization and phospholipase C activation in human platelets.
    Pulcinelli FM, Pignatelli P, Riondino S, Parisi S, Castiglioni C, Gazzaniga PP.
    Thromb Res; 1994 Jun 01; 74(5):453-61. PubMed ID: 8085246
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of the persisting TxA2 receptor antagonism by picotamide.
    Pulcinelli FM, Pignatelli P, Pesciotti M, Sebastiani S, Parisi S, Gazzaniga PP.
    Thromb Res; 1997 Feb 01; 85(3):207-15. PubMed ID: 9058495
    [Abstract] [Full Text] [Related]

  • 14. Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood.
    Anfossi G, Parisi S, Russo I, Mularoni EM, Massucco P, Cavalot F, Mattiello L, Trovati M.
    Thromb Res; 1995 Mar 01; 77(5):399-410. PubMed ID: 7778055
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of the effect of picotamide on platelet function in diabetic subjects].
    Carleo R, Veno L, Fuccio F, Bonavita M, De Matteo A, Gallo M, Gatti A, Gobbo M, Nocerino L.
    Boll Soc Ital Biol Sper; 1990 Jul 01; 66(7):647-54. PubMed ID: 2083059
    [Abstract] [Full Text] [Related]

  • 16. Competitive inhibition of platelet thromboxane A2 receptor binding by picotamide.
    Modesti PA, Colella A, Abbate R, Gensini G, Neri Serneri G.
    Eur J Pharmacol; 1989 Oct 04; 169(1):85-93. PubMed ID: 2532145
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of arachidonic acid induced-aggregation of rabbit platelets with CV-4151 (isbogrel), a selective thromboxane A2 (TXA2) synthase inhibitor: modulation of the antiplatelet action and prostanoid metabolism by rat aortic rings.
    Terashita Z, Imura Y, Nishikawa K.
    J Lipid Mediat Cell Signal; 1996 Jan 04; 13(1):1-8. PubMed ID: 8821806
    [Abstract] [Full Text] [Related]

  • 18. The role of extraplatelet thromboxane A2 in unstable angina investigated with a dual thromboxane A2 inhibitor: importance of activated monocytes.
    Neri Serneri GG, Gensini GF, Poggesi L, Modesti PA, Rostagno C, Boddi M, Gori AM, Martini F, Ieri A, Margheri M.
    Coron Artery Dis; 1994 Feb 04; 5(2):137-45. PubMed ID: 8180744
    [Abstract] [Full Text] [Related]

  • 19. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R, Nenci GG, Gresele P.
    J Pharmacol Exp Ther; 1995 Dec 04; 275(3):1497-505. PubMed ID: 8531121
    [Abstract] [Full Text] [Related]

  • 20. Selective thromboxane synthetase inhibition by picotamide and effects on endotoxin-induced lethality.
    Matera G, Chisari M, Altavilla D, Foca A, Cook JA.
    Proc Soc Exp Biol Med; 1988 Jan 04; 187(1):58-61. PubMed ID: 3277192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.